Biotron Limited Stock Today
| BITRF Stock | USD 0.01 0.04 89.94% |
PerformanceModest
| Odds Of DistressBelow Average
|
Biotron is trading at 0.005 as of the 1st of March 2025. This is a 89.94 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.005. Biotron has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 30th of January 2025 and ending today, the 1st of March 2025. Click here to learn more.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 901.94 M outstanding shares. More on Biotron Limited
Moving against Biotron Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biotron Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Biotron Limited [BITRF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotron's market, we take the total number of its shares issued and multiply it by Biotron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotron Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 901.94 M outstanding shares.
Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations.
Check Biotron Probability Of Bankruptcy
Ownership AllocationBiotron holds a total of 901.94 Million outstanding shares. Biotron Limited shows 14.13 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biotron Ownership Details
Biotron Limited Risk Profiles
| Mean Deviation | 9.78 | |||
| Standard Deviation | 39.73 | |||
| Variance | 1578.43 | |||
| Risk Adjusted Performance | 0.0712 |
Biotron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biotron without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Other Information on Investing in Biotron Pink Sheet
Biotron financial ratios help investors to determine whether Biotron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotron with respect to the benefits of owning Biotron security.